Abstract
We describe the long-term survival of a patient following the diagnosis of primary gastric small cell carcinoma. In January 2000, a 73-year-old male was found to have advanced gastric small cell carcinoma directly invading his liver. He received combination chemotherapy with cisplatin and irinotecan as first-line chemotherapy, then cisplatin and etoposide as second-line chemotherapy. He had a complete response after four cycles of second-line chemotherapy. In March 2001, the tumor recurred in the stomach and the patient underwent a total gastrectomy. He has survived free of disease for more than 2 years after the first diagnosis.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Carcinoma, Small Cell / drug therapy
-
Carcinoma, Small Cell / mortality*
-
Carcinoma, Small Cell / pathology
-
Carcinoma, Small Cell / surgery
-
Combined Modality Therapy
-
Gastrectomy
-
Gastric Mucosa / pathology
-
Gastroscopy
-
Humans
-
Male
-
Neoadjuvant Therapy
-
Neoplasm Recurrence, Local / drug therapy
-
Neoplasm Recurrence, Local / mortality
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / surgery
-
Stomach Neoplasms / drug therapy
-
Stomach Neoplasms / mortality*
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery
-
Survivors*
-
Tomography, X-Ray Computed
-
Uterine Cervical Dysplasia